KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non-Current Assets (2016 - 2025)

Sarepta Therapeutics has reported Other Non-Current Assets over the past 15 years, most recently at $5.2 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $5.2 million for Q4 2025, up 354.47% from a year ago — trailing twelve months through Dec 2025 was $5.2 million (up 354.47% YoY), and the annual figure for FY2025 was $5.2 million, up 354.47%.
  • Other Non-Current Assets for Q4 2025 was $5.2 million at Sarepta Therapeutics, up from $4.2 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for SRPT hit a ceiling of $278.6 million in Q1 2022 and a floor of $1.1 million in Q4 2024.
  • Median Other Non-Current Assets over the past 5 years was $12.1 million (2023), compared with a mean of $68.9 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 8020.03% in 2022 and later plummeted 99.17% in 2024.
  • Sarepta Therapeutics' Other Non-Current Assets stood at $2.0 million in 2021, then surged by 8020.03% to $163.0 million in 2022, then fell by 16.08% to $136.8 million in 2023, then plummeted by 99.17% to $1.1 million in 2024, then soared by 354.47% to $5.2 million in 2025.
  • The last three reported values for Other Non-Current Assets were $5.2 million (Q4 2025), $4.2 million (Q3 2025), and $83.1 million (Q2 2025) per Business Quant data.